Pancreatic ductal adenocarcinoma and invasive intraductal papillary mucinous tumor: Different prognostic factors for different overall survival
Digestive and Liver Diseases — Gavazzi F, Capretti G, Giordano L, et al. | July 02, 2021
This retrospective study was undertaken to compare prognostic characteristics of resected pancreatic ductal adenocarcinoma (PDAC) and invasive intraductal papillary mucinous neoplasm (IPMN). Data were analyzed for 332 patients (PDAC, n = 289; invasive IPMN, n = 43). Better overall survival was experienced by patients with invasive IPMN vs PDAC patients. A significantly higher risk of death was observed in relation to PDAC histology vs IPMN. In early-stage PDAC (IA-IB-IIA, N0), a worse survival was observed. Overall, findings showed better prognosis in IPMN vs PDAC cases, irrespective of disease stage.